Skip to main content
. Author manuscript; available in PMC: 2012 Jun 27.
Published in final edited form as: Am J Geriatr Pharmacother. 2012 Jan 27;10(2):139–150. doi: 10.1016/j.amjopharm.2012.01.001

Table 1.

Evidence from the scientific literature about age-related reduction in systemic clearance of antidepressants

Class/Agent Age-related reduction in clearance Reference
MAOI
Isocarboxazid N/A
Phenelzine N/A
Selegiline N/A
Tranylcypromine N/A
Other Antidepressants
Bupropion Yes [27]
Mirtazapine N/A
Nefazodone N/A
Methylphenidate N/A
Trazodone Yes [28,29]
Vilazodone N/A
SNRI
Desvenlafaxine Yes [30]
Duloxetine N/A
Venlafaxine Yes+ [30]
SSRI
Citalopram Yes [3133]
Escitalopram Yes [31, 32]
Fluoxetine N/A
Paroxetine N/A
Sertraline Yes [34]
Tetracyclics
Amoxapine N/A
Maprotiline No [35]
Trimipramine N/A
TCA
Amitriptyline Yes [3638]
Desipramine No [39]
Doxepin Yes [40,41]
Imipramine Yes [35,39,42]
Nortriptyline Yes [43,44]
*

renal clearance may be impaired with age; avoid use in creatinine clearance < 30ml/minute

+

men only; dose reduction recommended with reduced creatinine clearance

Abbreviations: MAOI=monamine oxidase inhibitor; NA= none available; SNRI=selective norepinephrine reuptake inhibitor, SSRI= selective serotonin reuptake inhibitor; TCA=tricyclic antidepressant